These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1697386)

  • 1. Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: involvement of endothelium-derived relaxing factor.
    Humphries RG; Tomlinson W; O'Connor SE; Leff P
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):292-7. PubMed ID: 1697386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries.
    Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC
    Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of co-dergocrine on platelet aggregation.
    Santos RO; Rodrigues R
    Braz J Med Biol Res; 1990; 23(3-4):325-7. PubMed ID: 2094545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation.
    Golino P; Cappelli-Bigazzi M; Ambrosio G; Ragni M; Russolillo E; Condorelli M; Chiariello M
    Circ Res; 1992 Dec; 71(6):1447-56. PubMed ID: 1423938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.
    Furlong B; Henderson AH; Lewis MJ; Smith JA
    Br J Pharmacol; 1987 Apr; 90(4):687-92. PubMed ID: 3495310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of organotins on rat platelet aggregation mechanisms.
    Knowles CO; Johnson TL
    Environ Res; 1986 Feb; 39(1):172-9. PubMed ID: 3943507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of urethane and thiopental sodium on platelet aggregation in vitro and in vivo.
    Evangelista S; Abelli L; Maggi CA; Meli A
    J Pharmacol Methods; 1984 Sep; 12(2):107-12. PubMed ID: 6443135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The suppressive effect of pyrrole-2-carboxylic acid on platelet aggregation].
    Komiyama K; Tronquet C; Hirokawa Y; Funayama S; Satoh O; Umezawa I; Oishi S
    Jpn J Antibiot; 1986 Mar; 39(3):746-50. PubMed ID: 3090299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
    Judge S; Mammen E; Dunbar JC
    J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of estrogen on platelet aggregation in guinea pigs.
    Yuan RY; Lee TK
    Taiwan Yi Xue Hui Za Zhi; 1989 Oct; 88(10):978-81. PubMed ID: 2634732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lomefloxacin and sparfloxacin on human platelet aggregation.
    Losasso C; Loffreda A; Angrisani M; Contaldi C; Cazzola M; Rossi F
    J Chemother; 1995 Oct; 7(5):420-3. PubMed ID: 8596124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nebivolol on human platelet aggregation.
    Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.
    Bult H; Fret HR; Van den Bossche RM; Herman AG
    Br J Pharmacol; 1988 Dec; 95(4):1308-14. PubMed ID: 3064856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet shape change and Ca2+ mobilization induced by collagen, but not thrombin or ADP, are inhibited by phenylarsine oxide.
    Greenwalt DE; Tandon NN
    Br J Haematol; 1994 Dec; 88(4):830-8. PubMed ID: 7819106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of unstimulated neutrophils on platelet aggregation by release of a factor similar to endothelium-derived relaxing factor (EDRF).
    Nicolini FA; Mehta JL
    Biochem Pharmacol; 1990 Nov; 40(10):2265-9. PubMed ID: 2244928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
    Bassenge E
    Eur Heart J; 1991 Nov; 12 Suppl E():12-5. PubMed ID: 1665128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin.
    Macdonald PS; Read MA; Dusting GJ
    Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.